Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $7.20M in the twelve months ending September 30, 2023, with 49.15% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $2.53M with 19.70% year-over-year growth. In the year 2022, Bolt Biotherapeutics had annual revenue of $5.73M with 354.68% growth.

• Revenue (ttm): $7.20M
• Revenue Growth: +49.15%
• P/S Ratio: 4.90
• Revenue / Employee: $76,574
• Employees: 94
• Market Cap: 35.30M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	5.73M	4.47M	354.68%
Dec 31, 2021	1.26M	1.03M	445.45%
Dec 31, 2020	231.00K	16.00K	7.44%
Dec 31, 2019	215.00K	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.